BLACK DIAMOND THERAPEUTICS, INC. Other Noncash Income (Expense)
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) reported Other Noncash Income (Expense) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2023-03-09
- BLACK DIAMOND THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2022-12-31 was $0.00.
- BLACK DIAMOND THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. other noncash income (expense) for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- BLACK DIAMOND THERAPEUTICS, INC. other noncash income (expense) for fiscal 2021 was $5.00K.
- BLACK DIAMOND THERAPEUTICS, INC. other noncash income (expense) for fiscal 2020 was $0.00.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $0.00 derived: sum of 2 quarters · filed 2023-03-09 | $0.00 derived: sum of 3 quarters · filed 2023-03-09 | $0.00 10-K · filed 2023-03-09 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | -$10.00K derived: sum of 4 quarters · filed 2023-03-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | -$10.00K derived: sum of 3 quarters · filed 2023-03-09 | -$9.00K derived: sum of 4 quarters · filed 2023-03-09 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-11 | -$10.00K derived: sum of 2 quarters · filed 2023-03-09 | -$9.00K derived: sum of 3 quarters · filed 2023-03-09 | $4.00K derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$9.00K derived: sum of 2 quarters · filed 2023-03-09 | $4.00K derived: sum of 3 quarters · filed 2023-03-09 | $5.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $14.00K derived: sum of 2 quarters · filed 2022-11-08 | $15.00K 10-Q · filed 2022-11-08 | $15.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $14.00K 10-Q · filed 2022-08-09 | $14.00K derived: sum of 3 quarters · filed 2022-08-09 | $14.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-11 | $1.00K derived: sum of 2 quarters · filed 2022-05-11 | $1.00K derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $0.00 10-K · filed 2022-03-17 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $0.00 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |